Jounce Therapeutics Inc.

Start Up

The field known as “immune oncology” is blazing hot right now and Jounce Therapeutics Inc. is one of the best-funded start-ups in the area. It launched in September 2013 with $47 million from Third Rock Ventures, and it’s structured to leverage the expertise of scientists who have been at the forefront of immune oncology for a decade.